Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AMS/VVY stock hub

AMS/VVY has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

AMS/VVYis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
37.9M
Euronext Amsterdam
Market data

Price

Recent price action with selectable time range.

AMS/VVYAMS/VVY
—
Loading chart…
In the news

Latest news · AMS/VVY

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-140.4
P25 n/aP50 n/aP75 n/a
ROIC-86.9
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All AMS/VVY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
158
Groups with data
11
Currency
EUR
Showing 158 of 158 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
Netherlands
Country code
NL
Employees
14
Employees Change
-1%
Employees Change Percent
-6.67
Enterprise value
EUR 32.4M
Exchange
Euronext Amsterdam
Financial currency
EUR
First seen
2026-05-10
Industry
Biotechnology
Isin
NL00150002Q7
Last refreshed
2026-05-10
Market cap
EUR 37.9M
Price
EUR 1.28
Price currency
EUR
Sector
Healthcare
Sic
2836
Symbol
ams/VVY
Website
https://www.vivoryon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

5
MetricValue
Earnings Yield
-23.35%
EV Earnings
-3.66x
EV/FCF
-3.83x
FCF yield
-22.32%
P/B ratio
8.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

10
MetricValue
Net Income
EUR -8.9M
Net Income Growth Quarters
3%
Net Income Growth Years
2%
Profit Per Employee
EUR -681,000
ROA
-59.25
Roa5y
-54.8
ROCE
-133.4
ROE
-140.4
Roe5y
-111.6
ROIC
-86.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr10y
-24.36%
Cagr1y
-26.54%
Cagr3y
-59.37%
Cagr5y
-38.38%
EPS Growth Quarters
3
EPS Growth Years
3
Revenue Growth Years
0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Assets
EUR 7.5M
Cash
EUR 5.6M
Current Assets
EUR 6.4M
Current Liabilities
EUR 837,000
Debt
EUR 108,000
Debt Equity
EUR 0.02
Debt FCF
EUR -0.01
Equity
EUR 4.7M
Interest Coverage
-198
Liabilities
EUR 2.8M
Long Term Assets
EUR 1.1M
Long Term Liabilities
EUR 2M
Net Cash
EUR 5.5M
Net Cash By Market Cap
EUR 14.54
Net Cash Growth
-40.51%
Net Debt Equity
EUR -1.17
Tangible Book Value
EUR 3.9M
Tangible Book Value Per Share
EUR 0.13
WACC
11.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

4
MetricValue
Current ratio
7.68
Net Working Capital
EUR 35,000
Quick ratio
7.2
Working Capital
EUR 5.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-3.53%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

38
MetricValue
10Y total return
-93.87%
1Y total return
-26.52%
200-day SMA
1.5
3Y total return
-93.3%
50-day SMA
1.34
50-day SMA vs 200-day SMA
50under200
5Y total return
-91.11%
All Time High
27.73
All Time High Change
-95.38%
All Time High Date
2016-01-11
All Time Low
0.41
All Time Low Change
212.2%
All Time Low Date
2024-04-17
ATR
0.05
Beta
1.37
Beta1y
0.3
Beta2y
0.24
Ch YTD
-9.86
High
1.3
High52
1.84
High52 Date
2025-10-10
High52ch
-30.43%
Low
1.27
Low52
1.2
Low52 Date
2026-04-24
Low52ch
6.67%
Ma50ch
-4.33%
Price vs 200-day SMA
-14.61%
RSI
42.04
RSI Monthly
34.81
RSI Weekly
32.66
Sharpe ratio
-0.98x
Sortino ratio
-1.33
Total Return
-3.53%
Tr YTD
-9.86
Tr1m
-0.78%
Tr1w
-2.66%
Tr3m
-10.36%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

1
MetricValue
Operating Income
EUR -8.9M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
25,320,303%
Net Borrowing
-61,000
Shares Insiders
8.11%
Shares Institutions
10.19%
Shares Out
29,614,327
Shares Qo Q
6.57%
Shares Yo Y
3.53%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

47
MetricValue
Adjusted FCF
EUR -9.4M
Average Volume
45,190.85x
Bv Per Share
0.16
CAPEX
EUR -6,000
Ch10y
-94.02
Ch1m
-0.78
Ch1w
-2.66
Ch1y
-26.52
Ch3m
-10.36
Ch3y
-93.3
Ch5y
-91.11
Ch6m
-21.95
Change
-1.16%
Change From Open
-1.16
Close
1.3
Days Gap
0
Depreciation Amortization
85,000
Dollar Volume
17,683.2
Earnings Date
2026-04-23
EBIT
EUR -8.9M
EBITDA
EUR -8.8M
EPS
EUR -0.33
F Score
2
FCF
EUR -8.5M
FCF EV Yield
-26.12x
FCF Per Share
EUR -0.29
Financing CF
4,715,000
Fiscal Year End
December
Founded
1,997
Investing CF
-6,000
Is Primary Listing
1
Last Earnings Date
2026-04-23
Last Report Date
2025-12-31
Ma150
1.48
Ma150ch
-13.63%
Ma20
1.31
Ma20ch
-2.59%
Net CF
-3,746,000
Open
1.3
Position In Range
33.33
Ppne
121,000
Price Date
2026-05-08
Ptbv Ratio
9.65
Relative Volume
0.31x
Share Based Comp
893,000
Tr6m
-21.95%
Volume
13,815
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does AMS/VVY pay a dividend?

Capital-return profile for this ticker.

Performance

AMS/VVY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-26.5%
S&P 500 1Y: n/a
3Y total return
-93.3%
S&P 500 3Y: n/a
5Y total return
-91.1%
S&P 500 5Y: n/a
10Y total return
-93.9%
S&P 500 10Y: n/a
Ownership

Who owns AMS/VVY?

Insider, institutional, and short-interest positioning.

Institutional ownership
+10.2%
Share of float held by funds and institutions
Insider ownership
+8.1%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+3.5%
Negative means the company is buying back shares.
Technical

AMS/VVY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
42.0
Neutral momentum band
Price vs 200-day MA
-14.6%
50/200-day relationship not available
Beta (5Y)
1.37
More volatile than the market
Sharpe ratio
-0.98
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About AMS/VVY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ams/VVY stock rating?

ams/VVY is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ams/VVY analysis?

The full report lives at /stocks/ams/VVY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ams/VVY?

The latest report frames ams/VVY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ams/VVY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.